Quality of life in chronic myeloid leukaemia patients after haematopoietic cell transplantation pretreated with second-generation tyrosine kinase inhibitors

AIM OF THE STUDY: The majority of patients with chronic myeloid leukaemia (CML) respond to tyrosine kinase inhibitors (TKI), while allogeneic haematopoietic cell transplantation (HCT) is indicated in selected clinical situations. HCT carries the risk of severe complications, while the toxicity profi...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Contemp Oncol (Pozn)
Main Authors: Piekarska, Agnieszka, Gil, Lidia, Jakitowicz, Karolina, Prejzner, Witold, Komarnicki, Mieczysław, Hellmann, Andrzej
Formato: Artigo
Idioma:Inglês
Publicado em: Termedia Publishing House 2016
Assuntos:
Original Paper
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5371710/
https://ncbi.nlm.nih.gov/pubmed/28373825
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5114/wo.2016.64607
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados